Tag: patent litigation

Paragraph IV Certifications: How Generic Drugs Challenge Pharmaceutical Patents

Learn how Paragraph IV certifications allow generic drug makers to challenge pharmaceutical patents, triggering the Hatch-Waxman Act and enabling cheaper medication access.